Fusion Pharmaceuticals
reduced tumor growth observed in all dose groups following challenge in contralateral flank tumor mess tumor | Fusion Pharmaceuticals
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
32 of 49
Related slides by other companies
BAT
Results
July 2020
strong growth up a | BAT
Pershing Square
Activist
October 2018
reduced long term growth targets | Pershing Square
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights